The drugmaker said one patient became ill after being treated with its experimental weight-loss drug, danuglipron.

You’ve viewed 1 of 5 articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.

In a Q&A with Jeff Casberg, MS, RPh, senior vice president of clinical pharmacy services at IPD Analytics, Casberg explains ...

During a recent panel discussion sponsored by Purdue University, industry leaders explain how the technology is revolutionizing drug development and production ...

The Centers for Medicare and Medicaid Services estimates U.S. health care spending will grow 5.6% annually through 2032, ...

Isomorphic Labs raised $600 million in its first external funding round to boost its artificial-intelligence drug design pipeline across multiple therapeutic ... investment to advance its AI research ...

Pfizer will halt its development of a weight-loss drug that was being closely watched by investors, in a significant blow to the US pharmaceutical group. The company said on Monday that it would stop ...

| Discover how AI and RWD are transforming drug development by optimizing clinical trial protocols, enhancing recruitment, ...

It covers the pipeline drug profiles, including clinical and ... The therapies under development are focused on novel approaches to treat/improve Microbiome Disease. This segment of the Microbiome ...

Not only does this shorten the path to drug development and improve safety, but it helps create a more robust pipeline of disease-treating therapies at a faster pace than ever before. The human ...

This should not only speed up the research and development pipeline for new drugs, but also hugely reduce the number of laboratory animals required. New active ingredients such as antibodies are ...

The table below is a review of notable updates that occurred in March 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.